Loading
Life sciences · Journal article
Cell Death and Disease · October 22, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Epithelial cell identity is maintained by coordinated transcriptional and epigenetic programs that preserve tissue integrity and restrain epithelial–mesenchymal transition (EMT)–driven plasticity. Through integrative transcriptomic and chromatin accessibility analyses of human mammary epithelial cells, we identify the homeobox transcription factor PITX1 as a master regulator of epithelial fate and a potent suppressor of EMT. Loss of PITX1 alone is sufficient to induce transcriptional reprogramming, cytoskeletal remodeling, and morphological shifts characteristic of EMT, comparable to those elicited by TGF-β stimulation. Conversely, restoration of PITX1 in aggressive breast cancer cells markedly reduces their migratory capacity. In patient tumors, PITX1 is enriched in epithelial compartments and EMT‑low subtypes, but downregulated in mesenchymal‑like cancers. Clinically, high PITX1 expression correlates with lower tumor grade, improved survival, and enhanced chemotherapy sensitivity, whereas its loss marks aggressive, therapy‑resistant disease. Mechanistically, PITX1 directly binds and represses genes encoding core EMT drivers, thereby maintaining epithelial gene expression programs and establishing an epigenetic barrier to mesenchymal transition.